Bill Sponsor
Senate Bill 4742
116th Congress(2019-2020)
CLINICAL TREATMENT Act
Introduced
Introduced
Introduced in Senate on Sep 29, 2020
Overview
Text
Introduced
Sep 29, 2020
Latest Action
Sep 29, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4742
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
North Carolina
Democrat
Maryland
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act or the CLINICAL TREATMENT Act

This bill requires state Medicaid programs to cover routine patient costs for items and services that are provided in connection with a qualifying clinical trial regarding serious or other life-threatening conditions.

The bill defines routine patient costs to include items and services that would otherwise be covered under Medicaid absent the patient's participation in the clinical trial; the term includes items and services relating to trial complications, but excludes those items and services that are the subject of the trial or that are provided solely in relation to data analysis and are not otherwise covered.

Additionally, a qualifying clinical trial means, among other things, a clinical trial that is approved or funded by specified entities (e.g., the National Institutes of Health) or is an authorized new drug trial.

Text (1)
September 29, 2020
Actions (2)
09/29/2020
Read twice and referred to the Committee on Finance.
09/29/2020
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:44:40 PM